Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 18 studies | 32% ± 15% | |
glutamatergic neuron | 10 studies | 38% ± 23% | |
myofibroblast cell | 10 studies | 26% ± 12% | |
epithelial cell | 10 studies | 39% ± 19% | |
smooth muscle cell | 10 studies | 22% ± 9% | |
astrocyte | 10 studies | 31% ± 11% | |
oligodendrocyte precursor cell | 10 studies | 35% ± 15% | |
GABAergic neuron | 9 studies | 42% ± 23% | |
connective tissue cell | 9 studies | 42% ± 19% | |
pericyte | 9 studies | 24% ± 9% | |
neuron | 8 studies | 41% ± 20% | |
mesothelial cell | 8 studies | 38% ± 18% | |
endothelial cell | 8 studies | 30% ± 13% | |
ciliated cell | 8 studies | 28% ± 9% | |
basal cell | 7 studies | 28% ± 9% | |
endothelial cell of lymphatic vessel | 7 studies | 25% ± 15% | |
type II pneumocyte | 7 studies | 24% ± 8% | |
adipocyte | 7 studies | 27% ± 12% | |
progenitor cell | 6 studies | 28% ± 14% | |
interneuron | 6 studies | 52% ± 21% | |
club cell | 6 studies | 29% ± 10% | |
type I pneumocyte | 6 studies | 29% ± 12% | |
goblet cell | 6 studies | 34% ± 9% | |
plasmacytoid dendritic cell | 6 studies | 23% ± 5% | |
plasma cell | 5 studies | 28% ± 9% | |
respiratory goblet cell | 5 studies | 28% ± 15% | |
abnormal cell | 5 studies | 33% ± 12% | |
amacrine cell | 5 studies | 28% ± 10% | |
cardiac muscle cell | 5 studies | 32% ± 4% | |
oligodendrocyte | 5 studies | 24% ± 9% | |
pancreatic A cell | 4 studies | 47% ± 30% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 21% ± 3% | |
T cell | 4 studies | 21% ± 3% | |
retinal ganglion cell | 4 studies | 38% ± 16% | |
pro-B cell | 4 studies | 35% ± 13% | |
retina horizontal cell | 4 studies | 29% ± 8% | |
lymphocyte | 4 studies | 24% ± 5% | |
hepatocyte | 4 studies | 43% ± 20% | |
secretory cell | 3 studies | 32% ± 13% | |
neural crest cell | 3 studies | 19% ± 2% | |
GABAergic interneuron | 3 studies | 35% ± 4% | |
granule cell | 3 studies | 26% ± 7% | |
microglial cell | 3 studies | 23% ± 7% | |
retinal bipolar neuron | 3 studies | 23% ± 5% | |
GABAergic amacrine cell | 3 studies | 29% ± 2% | |
Mueller cell | 3 studies | 24% ± 10% | |
glycinergic amacrine cell | 3 studies | 27% ± 2% | |
enteroendocrine cell | 3 studies | 36% ± 17% | |
kidney loop of Henle epithelial cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 4965.56 | 328 / 328 | 100% | 123.02 | 178 / 178 |
prostate | 100% | 7763.48 | 245 / 245 | 100% | 250.00 | 500 / 502 |
ovary | 100% | 9087.34 | 180 / 180 | 100% | 144.31 | 428 / 430 |
brain | 99% | 10071.99 | 2622 / 2642 | 100% | 281.89 | 705 / 705 |
thymus | 100% | 11302.57 | 653 / 653 | 99% | 140.96 | 600 / 605 |
adrenal gland | 100% | 17164.82 | 258 / 258 | 98% | 220.06 | 226 / 230 |
breast | 100% | 5337.70 | 458 / 459 | 98% | 185.45 | 1100 / 1118 |
skin | 99% | 9629.82 | 1791 / 1809 | 99% | 191.11 | 467 / 472 |
lung | 99% | 6058.15 | 575 / 578 | 98% | 134.84 | 1130 / 1155 |
intestine | 100% | 5336.90 | 965 / 966 | 95% | 79.36 | 503 / 527 |
bladder | 100% | 5302.33 | 21 / 21 | 94% | 108.22 | 475 / 504 |
stomach | 100% | 5081.47 | 359 / 359 | 92% | 79.71 | 264 / 286 |
kidney | 100% | 5669.82 | 89 / 89 | 92% | 72.98 | 828 / 901 |
esophagus | 99% | 3832.02 | 1429 / 1445 | 92% | 81.31 | 169 / 183 |
uterus | 99% | 7583.04 | 169 / 170 | 89% | 136.12 | 410 / 459 |
liver | 100% | 4722.91 | 225 / 226 | 85% | 86.33 | 347 / 406 |
spleen | 100% | 5154.54 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 79.38 | 1 / 1 |
blood vessel | 100% | 7816.84 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 4468.05 | 1197 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 117.05 | 79 / 80 |
lymph node | 0% | 0 | 0 / 0 | 97% | 63.23 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 90.17 | 43 / 45 |
heart | 93% | 5625.96 | 800 / 861 | 0% | 0 | 0 / 0 |
muscle | 92% | 3164.47 | 742 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 24% | 2060.33 | 226 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0090190 | Biological process | positive regulation of branching involved in ureteric bud morphogenesis |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MAGED1 |
Protein name | Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog) |
Synonyms | PRO2292 NRAGE PP2250 |
Description | FUNCTION: Involved in the apoptotic response after nerve growth factor (NGF) binding in neuronal cells. Inhibits cell cycle progression, and facilitates NGFR-mediated apoptosis. May act as a regulator of the function of DLX family members. May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Plays a role in the circadian rhythm regulation. May act as RORA co-regulator, modulating the expression of core clock genes such as BMAL1 and NFIL3, induced, or NR1D1, repressed. . |
Accessions | ENST00000375722.5 [Q9Y5V3-1] ENST00000326587.12 [Q9Y5V3-1] ENST00000375695.2 [Q9Y5V3-2] Q9Y5V3 ENST00000375772.7 [Q9Y5V3-1] |